Skip to main content
Premium Trial:

Request an Annual Quote

DeCode s Nuptials With MediChem May Come Sooner Than Planned

NEW YORK, Feb. 21 - DeCODE Genetics will likely acquire MediChem Life Sciences faster that it expected.

 

On Thursday the companies said that the US Federal Trade Commission has ended the Hart-Scott-Rodino waiting period ahead of time, meaning that the proposed merger is now expected to close in mid-March, several weeks before the firms originally expected the deal to close.

The transaction is still subject to a vote by MediChem stockholders, who are set to gather at a meeting on March 14.

As GenomeWeb reported, deCode in early January announced plans to acquire MediChem in a stock-swap deal valued at roughly $84 million. The deal is hoped to bolster the Icelandic population genomics company's chemistry and structural proteomics technology and to accelerate its progress toward in-house drug discovery and development.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.